SOURCE: Signal Watch

Signal Watch

November 30, 2011 08:05 ET

Analytical Reports on Celgene Corporation and Biogen Idec Inc. - Influx of New Products and Uses in Biotech Industry

NEW YORK, NY--(Marketwire - Nov 30, 2011) - provides members with proprietary analysis of over 10,000 stocks which is updated every day. Today, members can receive their complimentary stock analysis on Celgene Corporation (NASDAQ: CELG) and Biogen Idec Inc. (NASDAQ: BIIB). Sign up now on to get your free reports on these stocks.

While there has been much talk about expiring patents and patent cliffs of late, a number of new products coming out of the Healthcare Biotechnology Industry are in the late stages of trials or are waiting for an FDA ruling. New products have continued to come down the research and development pipeline, and companies such as Celgene Corp. and Biogen Idec Inc. are hoping that the time and effort required to bring their products to market pays off. gives traders a unique insight about Celgene Corporation and Biogen Idec Inc. by registering now at or brings investors free classic analysis on Celgene Corporation, Biogen Idec Inc. and other companies within the Biotechnology industry. This type of analysis is only a fragment of the information members have available to them. To learn more we encourage investors to sign up at

Some companies have also been looking into alternative uses for existing products, in an effort to boost sales.

Many in the industry, including Biogen and Celgene, have been able to grow revenues in year over year third quarter comparisons, and a number of companies have cited increased sales from emerging and foreign markets as part of the cause. Overseas approval from the European Medicines Agency has also helped in some cases.

About Signal Watch

Signal Watch's #1 goal is to help customers successfully engage the markets. For over 20 years, we have been developing the most powerful trading software available anywhere. But the software is only part of our mission. We also provide education and customer support designed to enable our customers to take control of their financial future.

Read our disclaimer by clicking on the following link

Contact Information